Enhertu (trastuzumab deruxtecan) first HER2-directed medicine approved in a decade for patients with HER2-positive metastatic gastric cancer

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu…

by Elixi